BOSTON SCIENTIFIC CORP (BSX:NYSE)
$44.39 0.25 (0.5664%)
Analysed BOSTON SCIENTIFIC CORP (BSX:NYSE) News Sources
Boston Scientific Corporation (BSX) is Attracting Investor Attention: Here is What You Should Know
08-10-2026
yahoo.com
Boston Scientific (BSX) Advances While Market Declines: Some Information for Investors
08-10-2026
yahoo.com
Boston sues J&J subsidiary over alleged patent infringement for cardiology device
09-10-2026
medicaldevice-network.com
Why Boston Scientific (BSX) Outpaced the Stock Market Today
09-10-2026
yahoo.com
Global Bioelectronic Medicine Device Market 2026 | Capitalize on 17% CAGR Through 2030 as Medtronic, Abbott, Boston Scientific and LivaNova Advance Closed-Loop Neurostimulation
13-10-2026
yahoo.com
Earnings Preview: What to Expect From Boston Scientific’s Report
14-10-2026
barchart.com
What Could BSX Stock Be Worth In Three Years?
14-10-2026
trefis.com
Boston Scientific (BSX) Recalls 262,686 Catheters Over Life Threatening Tip Failure Risk
14-10-2026
yahoo.com
Is Boston Scientific Stock Riskier Than It Was A Year Ago?
15-10-2026
trefis.com
Boston Scientific (BSX) Rises Higher Than Market: Key Facts
15-10-2026
yahoo.com
What is the current price of BOSTON SCIENTIFIC CORP (BSX:NYSE)?
The current price of BOSTON SCIENTIFIC CORP (BSX:NYSE) is $44.39.
BOSTON SCIENTIFIC CORP (BSX:NYSE) absolute price change since previous trading day?
The absolute price change of BOSTON SCIENTIFIC CORP (BSX:NYSE) since the previous trading day is $0.25.
BOSTON SCIENTIFIC CORP (BSX:NYSE) percentage price change since previous trading day?
The percentage price change of BOSTON SCIENTIFIC CORP (BSX:NYSE) since the previous trading day is 0.5664%.
What is the most recent average sentiment score for BOSTON SCIENTIFIC CORP (BSX:NYSE)?
The most recent average sentiment score for BOSTON SCIENTIFIC CORP (BSX:NYSE) is 54 out of 100.
What is the most recent average sentiment for BOSTON SCIENTIFIC CORP (BSX:NYSE)?
The most recent sentiment for BOSTON SCIENTIFIC CORP (BSX:NYSE) is .
SEC-8K** Filing Available For BOSTON SCIENTIFIC CORP (BSX:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.